Increased Risk of Myositis Autoantibodies After COVID-19 Vaccination
Hospital Clínico San Carlos, Madrid, Spain
2024
n=788
publication
10 minutes
Evidence: moderate
García-Bravo Laura, Prada Alvaro, Gutiérrez Larrañaga María, Espinosa Ros Eduardo, Almeida González Delia, Martín Martínez Dolores, Rodríguez Sánchez Telesforo, Mingorance Gámez Carlos Gustavo, Jurado Roger Aurora, Aguado Álvarez Rocío, Díaz Luna María De Las Mercedes, Rodríguez Hernández Carmen, de la Varga-Martínez Raquel, López-Cueto María, Julià Benique Maria Rosa, San José-Cascón Miriam, Quirant-Sánchez Bibiana, Martínez-Chamorro Alba, Marcaida-Benito Goitzane, Timoneda Timoneda Pilar Teresa, Fandos Sánchez Marta, Sacristán Enciso Beatriz, Mohamed Mohamed Kauzar, Guerra-Galán Teresa, Villegas Ángela, Roncancio-Clavijo Andrés, Rodríguez-Mahou Margarita, Sánchez-Ramón Silvia, Fernández-Arquero Miguel, Candelas-Rodríguez Gloria, Ochoa-Grullón Juliana
Title
Increased Risk of Myositis Autoantibodies After COVID-19 Vaccination
Hypothesis
This study aimed to describe the incidence of idiopathic inflammatory myopathies (IIM) following SARS-CoV-2 infection or vaccination and compare rates between exposures.
Conclusion
The study found distinct patterns of myositis autoantibodies associated with SARS-CoV-2 infection and vaccination, indicating increased autoimmune risks.